TY - JOUR
T1 - Pleuroparenchymal fibroelastosis diagnosed by multidisciplinary discussions in Japan
AU - the Tokyo Diffuse Lung Disease Study Group
AU - Ishii, Hiroshi
AU - Watanabe, Kentaro
AU - Kushima, Hisako
AU - Baba, Tomohisa
AU - Watanabe, Satoshi
AU - Yamada, Yoshihito
AU - Arai, Toru
AU - Tsushima, Kenji
AU - Kondoh, Yasuhiro
AU - Nakamura, Yutaro
AU - Terasaki, Yasuhiro
AU - Hebisawa, Akira
AU - Johkoh, Takeshi
AU - Sakai, Fumikazu
AU - Takemura, Tamiko
AU - Kawabata, Yoshinori
AU - Ogura, Takashi
N1 - Funding Information:
This study is partially supported by the Practical Research Project for Rare Intractable Diseases from Japan Agency for Medical Research and Development , AMED . This study is also partially supported by a grant from the Ministry of Health, Labour and Welfare of Japan awarded to the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on intractable diseases ( 29080201 ). The annual meeting of Tokyo Diffuse Lung Disease Study Conference was held under the joint sponsorship of the Tokyo Diffuse Lung Disease Study Group and Shionogi Pharmaceutical Co., Ltd.
Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/8
Y1 - 2018/8
N2 - Background: Pleuroparenchymal fibroelastosis (PPFE) is a rare subset of idiopathic interstitial pneumonias. No large-scale clinical studies of PPFE have been published. The aim of the study was to clarify the clinical and physiological characteristics of PPFE in Japan Methods: This was a retrospective, nationwide, and multicenter study in Japan. We reviewed 52 patients with PPFE, diagnosed after multidisciplinary discussions. Results: Flat chest index, defined as the ratio of anteroposterior diameter to transverse diameter of thoracic cage at the level of 6th thoracic vertebra, correlated positively with body mass index (BMI) (r = 0.340, p = 0.013) and percentage of predicted value of forced vital capacity (FVC %pred) (r = 0.355, p = 0.012), and negatively with the ratio of residual volume to total lung capacity (RV/TLC) (r = −0.312, p = 0.042). RV/TLC correlated negatively with BMI (r = −0.746, p < 0.0001) and FVC %pred (r = −0.507, p = 0.0005), and positively with age, and physiological variables (GAP) scores (r = 0.332, p = 0.030). The median survival time and the cumulative 5-year survival rate were 96 months and 58%, respectively. Patients with KL-6 level >600 (U/mL) survived shorter than those with <600 (p < 0.001). Conclusion: Low BMI, decreased FVC and increased RV/TLC in PPFE may be related to the progression of flattened chest cage which impairs distension of chest cage at inspiration. Elevated serum levels of KL-6 suggest a poor prognosis of PPFE.
AB - Background: Pleuroparenchymal fibroelastosis (PPFE) is a rare subset of idiopathic interstitial pneumonias. No large-scale clinical studies of PPFE have been published. The aim of the study was to clarify the clinical and physiological characteristics of PPFE in Japan Methods: This was a retrospective, nationwide, and multicenter study in Japan. We reviewed 52 patients with PPFE, diagnosed after multidisciplinary discussions. Results: Flat chest index, defined as the ratio of anteroposterior diameter to transverse diameter of thoracic cage at the level of 6th thoracic vertebra, correlated positively with body mass index (BMI) (r = 0.340, p = 0.013) and percentage of predicted value of forced vital capacity (FVC %pred) (r = 0.355, p = 0.012), and negatively with the ratio of residual volume to total lung capacity (RV/TLC) (r = −0.312, p = 0.042). RV/TLC correlated negatively with BMI (r = −0.746, p < 0.0001) and FVC %pred (r = −0.507, p = 0.0005), and positively with age, and physiological variables (GAP) scores (r = 0.332, p = 0.030). The median survival time and the cumulative 5-year survival rate were 96 months and 58%, respectively. Patients with KL-6 level >600 (U/mL) survived shorter than those with <600 (p < 0.001). Conclusion: Low BMI, decreased FVC and increased RV/TLC in PPFE may be related to the progression of flattened chest cage which impairs distension of chest cage at inspiration. Elevated serum levels of KL-6 suggest a poor prognosis of PPFE.
KW - Forced vital capacity
KW - Idiopathic pulmonary fibrosis
KW - KL-6
KW - Pleuroparenchymal fibroelastosis
KW - RV/TLC
UR - http://www.scopus.com/inward/record.url?scp=85050151948&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050151948&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2018.06.022
DO - 10.1016/j.rmed.2018.06.022
M3 - Article
C2 - 30053966
AN - SCOPUS:85050151948
SN - 0954-6111
VL - 141
SP - 190
EP - 197
JO - British Journal of Tuberculosis and Diseases of the Chest
JF - British Journal of Tuberculosis and Diseases of the Chest
ER -